Troubadour Announces $1,250,000 Private Placement and New Interim CEO

Stock Information for NervGen Pharma Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NervGen Pharma Corp.

Troubadour Closes 100% Ownership of High-Grade Monarch Uranium Property
Troubadour to Acquire 100% Ownership of High-Grade Monarch Uranium Property
Troubadour Welcomes Chris Huggins to the Board of Directors
Troubadour Welcomes Blake Morgan to the Board of Directors
Troubadour Identifies New Multi-Element Soil Anomaly and Reports Rock Sample Results from the Texas Project
Troubadour Completes Field Program on the Texas Property and Closes Private Placement
Troubadour Mobilizes Crews for Robust Property-Scale Exploration on the Texas Property
Troubadour Stakes Additional Ground at the Texas Project

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.